FADS2 and metabolic dysfunction-associated steatotic liver disease: In the case of lowered desaturase activity within the liver (namely obesity-induced NAFLD), studies in HFD-fed mice showed upregulation of the SREBP-1c-dependent mRNA expression of fatty acid desaturase (FADS)1 and FADS2 [93].